Statistics
Publications
1
Citations
106
H-Index
1
Active since
2006
Affiliations
Houston Methodist(Current)
A. Misellati is an author at Houston Methodist specializing in mtor signaling, kidney cancer, and pharmacology.
Publications per year
2006–2006
1
1
A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
R. J. Amato, A. Misellati, Muhammad Khan et al. · Journal of Clinical Oncology · 2006 · 106 citations
Medicine, Oncology, Pharmacology +17
1–1 of 1